Non categorizzato AstraZeneca’s cell lung cancer drug sent for EU approval Novembre 18, 2024 0 commenti AstraZeneca Plc.’s treatment for patients with unresectable non-small cell lung cancer Tagrisso gained key recommendation for approval in the European Union, the company announced on Monday.The Commit… About the author:
Get involved!
Comments